<DOC>
	<DOCNO>NCT02825576</DOCNO>
	<brief_summary>The purpose study determine use sugammadex ( compare neostigmine ) reduce rate postoperative pulmonary complication ( PPCs ) .</brief_summary>
	<brief_title>Prevention Postoperative Events Following Reversal With Sugammadex Neostigmine</brief_title>
	<detailed_description>This local , multi-centre , prospective , randomise , double blind trial 976 patient . Objectives : The primary objective determine use sugammadex ( compare neostigmine ) reduce rate postoperative pulmonary complication ( PPCs ) . Secondary objective determine use sugammadex compare traditional reversal agent improve patient quality recovery , reduce rate postoperative nausea vomit reduces rate airway complication Post Anaesthesia Care Unit ( PACU ) . Study procedure : Following informed consent prior surgery , patient randomise two group allocate drug use reversal muscle relaxation ; 1 . 2mg/kg sugammadex 2 . 50mcg/kg neostigmine 10mcg/kg glycopyrrolate Randomisation via computer generate number , seal opaque , sequentially numbered envelope . Treating anaesthetist staff assess outcome blind treatment . Patients neuromuscular transmission ( NMT ) monitoring intraoperatively ensure return train-of-four count ( TOFC ) &gt; 2 prior reversal . Muscle relaxant limit rocuronium vecuronium , choice individual anaesthetist . As study plan 'real world ' trial , mode anaesthesia , analgesia , postoperative nausea vomiting ( PONV ) prophylaxis time reversal determine individual treating anaesthetist . Postoperative outcome data collect recovery unit , postoperative day 1 2 ( still inpatient ) , hospital discharge via 30 day post-operative phone call . Statistical Analysis : Conservatively estimate baseline incidence PPC 7 % baseline incidence equally conservative estimate sugammadex reduce 3 % would produce clinically relevant number need treat ( NNT ) 29 . Accepting alpha error 0.05 beta error 0.2 would require 930 patient . Allowing 5 % incomplete data loss follow require 976 patient . Groups analyse intention-to-treat basis 1 . PPC rate , QoR-15 score hospital stay assess continuous variable 2 . Post operative Nausea Vomiting ( PONV ) score assess ordinal variable 3 . Mortality presence respiratory PACU event assess categorical variable . The effect sugammadex continuous variable analyse 2-tailed Student T-test . The effect sugammadex ordinal categorical variable analyse Chi-squared test . Binomial regression analysis perform categorical outcome subgroup analysis . Logistic regression perform analyse effect PONV risk PONV score . Appropriate statistical test confirm test assumption meet perform . In case non-parametric data , appropriate test perform . Interim analysis plan 50 % data completion .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>age &gt; 18 patient present noncardiac surgery plan operative time 1 hour plan intubate receive muscle relaxant surgery plan stay least one night hospital Previous recruitment trial Hypersensitivity study drug Patient refusal Cognitive Impairment , language proficiency lead inability complete QoR15 questionnaire Body Mass Index ( BMI ) &gt; 40 Planned postoperative intubation ventilation Liver failure ChildPugh class B/C Renal failure either regular peritoneal haemodialysis serum creatinine &gt; 140mcgmol/L Women lactating , pregnant childbearing potential willing avoid pregnancy study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>